Alekss / Fotolia
Genetic engineering
Check carefully, approve safely.
The release of genetically modified organisms (GMO) for scientific trials needs to be approved by the BVL. If GMO are to be cultivated commercially, the BVL will provide a statement in the Community approval process of the EU. Furthermore, the BVL manages the international information exchange on GMO in the Biosafety Clearing House for Germany. The BVL hosts the secretary of the Central Committee on Biological Safety (ZKBS). The ZKBS advises the Federal Government and the Federal States in safety-relevant questions on genetic engineering.
Many topics, one goal
Authorisation procedure for the placing on the market of GMOs
Throughout Europe, commodities must undergo authorisation procedures prior to marketing authorisation being granted for GMOs or products made from GMOs.
Authorisation procedure for releases
Before authorisation is granted for GMOs to be released for experimental purposes, the application is checked by various public authorities in a national procedure involving the public.